Sid Sung
On December 31, 2023, Sid Sung resigned as the President of Iveda Solutions, Inc
Highest-materiality recent filing
Iveda Solutions receives Nasdaq bid price deficiency notice; has 180 days to comply
Nasdaq letter on March 6, 2026, cites failure to maintain $1 minimum bid price for 30 consecutive business days.
Iveda raises ~$2M in public offering of 5.7M shares and 11.4M warrants at $0.35/unit
Offering of 5,259,999 shares (or pre-funded warrants for 454,287 shares) and series X warrants for 11,428,572 shares at $0.35/unit.
Iveda Solutions holds 2024 Annual Meeting; re-elects four directors
Re-elected directors Farnsworth, Franco, Gillen, Ly; each received ~503k-508k votes for, ~52k-57k withheld.
Iveda Solutions regains Nasdaq compliance on equity requirement
Nasdaq previously warned company for failing $2.5M stockholders' equity minimum.
Iveda Solutions shareholders approve issuance of 1.25M warrants at $3.44 per share
Shareholders approved Proposal 5 to issue 625,000 Series A and 625,000 Series B warrants with a $3.44 exercise price.
Nasdaq grants Iveda Solutions extension to Nov 24, 2025 to regain equity compliance
Stockholders' equity of $1.7M as of March 31, 2025 fell below Nasdaq's $2.5M minimum.
Iveda Solutions' 2024 Annual Meeting fails to approve warrant issuance; adjourned to Aug 29
At reconvened 2024 Annual Meeting on June 2, 2025, Proposal 5 (issuance of 625K Series A and B warrants and underlying shares) did not receive sufficient votes.
Iveda receives Nasdaq deficiency notice for stockholders' equity below $2.5M
As of March 31, 2025, stockholders' equity was $1.7M, below Nasdaq's $2.5M minimum.
Iveda Solutions restates 2023 & 2024 financials; net losses increase by $1.4M-$1.6M
Restatement due to multiple errors including improper capitalization of software dev costs, deferred tax asset write-off, and intercompany payable.
Iveda shareholders approve redomicile to Delaware; warrant issuance vote adjourned to June 2
Redomicile from Nevada to Delaware approved: 1,233,381 for, 21,273 against, 19,553 abstained.
Iveda Solutions enters ATM offering agreement with H.C. Wainwright for up to $5.08M in common stock
Agreement with H.C. Wainwright & Co. to sell up to $5,082,431 of common stock in at-the-market offerings.
Iveda Solutions dismisses Kreit & Chiu CPA LLP, appoints Weinberg & Company as auditor
Dismissed Kreit & Chiu CPA LLP as independent auditor effective February 21, 2025.
Stockholders re-elected directors Farnsworth, Franco, Gillen, Ly (615-34K for each).
Iveda Solutions 1-for-8 reverse stock split effective Sept 17, 2024 to meet Nasdaq bid price rule
1-for-8 reverse stock split expected effective at market open on September 17, 2024; shares to trade under same symbol IVDA with new CUSIP 46583A303.
Iveda Solutions effects 1-for-4 reverse stock split, authorized shares cut to 9.375M
Reverse stock split at 1:4 ratio; outstanding shares drop from ~18.07M to ~4.52M.
Iveda Solutions raises ~$2.15M in registered direct offering and private placement
Sold 1.8M shares at $0.43/share and pre-funded warrants for 3.2M shares at $0.429/warrant; gross proceeds ~$2.15M.
Iveda dismisses BF Borgers as auditor after SEC order; appoints Kreit & Chiu
Dismissed BF Borgers CPA PC on May 9, 2024, following SEC administrative order dated May 3, 2024.
Iveda Solutions gets 180-day Nasdaq bid-price extension to Sept 23, 2024
Nasdaq extended compliance period to September 23, 2024 for minimum $1.00 bid price.
Iveda Solutions President Sid Sung resigns; CEO David Ly appointed President
Sid Sung resigned as President effective Dec 31, 2023, for personal reasons.
Iveda annual meeting passes four proposals; directors elected, auditor ratified, say-on-pay approved
Directors Farnsworth, Franco, Gillen, and Ly elected with 3.0-3.2M votes each; broker non-votes 4.78M.
Nasdaq notifies Iveda Solutions of non-compliance with minimum bid price rule
Closing bid price of common stock below $1.00 for 30 consecutive trading days.
Iveda Solutions regains Nasdaq minimum bid price compliance
Nasdaq notified Iveda on Feb 15, 2023, that its common stock closed at $1.00+ for 10 consecutive business days.
Iveda Solutions CMO/COO Luz Berg resigns; CFO Brilon named Corporate Secretary
Luz Berg resigned as CMO, COO and Corporate Secretary on Dec 31, 2022 for personal reasons.
Iveda Solutions receives Nasdaq deficiency notice for bid price below $1.00 for 30 days
Received Nasdaq notice on Oct 18, 2022 for non-compliance with minimum $1.00 bid price requirement; bid price below $1.00 for 30 consecutive trading days.
Iveda Solutions raises $5M via private placement of stock and warrants
Gross proceeds of $5M from sale of 3,289,474 shares (or pre-funded warrants) at $1.52/unit and 3,289,474 warrants.
Iveda closes $8M public offering, completes 1-for-8 reverse stock split, uplists to Nasdaq
Gross proceeds of $8.0M from offering of 1,885,000 shares and 2,164,700 warrants (including over-allotment) at $4.25 per unit.
Shareholders approve doubling of authorized common stock to 300M shares
Special meeting held Jan 21, 2022; 49,980,029 shares voted, representing 63.83% of outstanding.
On December 31, 2023, Sid Sung resigned as the President of Iveda Solutions, Inc
The Board of Directors has appointed David Ly, its Chairman of the Board of Directors and Chief Executive Officer as the President as of December 31, 2023.
The Board of Directors has appointed Robert J Brilon, its Chief Financial Officer and Treasurer, as the Corporate Secretary as of December 31, 2022.
On December 31, 2022, Luz Berg resigned as the Chief Marketing Officer, Chief Operating Officer and Corporate Secretary of Iveda Solutions, Inc (the “Company”).
Max materiality 0.85 · Median 0.60 · Most common event other_material